coiled-coil proteins at the Golgi apparatus capture vesicles from different origins, but the vesicle-specific molecular cues that they recognize are unknown [5] [6] [7] [8] . Vesicle tethering is typically a transient process and therefore is challenging to interrogate in vivo. Thus, we have used a system in which an ectopic golgin causes vesicles to accumulate in a tethered state. By applying proximity biotinylation to the golgin-captured vesicles, we identify TBC1D23, an apparently catalytically inactive member of a family of Rab GTPase-activating proteins (GAPs), as a vesicle-golgin adaptor that is required for endosome-to-Golgi trafficking. The Rab GAP domain of TBC1D23 binds to a conserved motif at the tip of golgin-245 and golgin-97 at the trans-Golgi, while the C terminus binds to the WASH complex on endosome-derived vesicles. Thus, TBC1D23 is a specificity determinant that links the vesicle to the target membrane during endosome-to-Golgi trafficking.
The Golgi apparatus receives transport vesicles originating from diverse compartments including the endoplasmic reticulum (ER), endosomes and from within the Golgi itself 7, 9, 10 . Studies on vesicle tethering at the Golgi have had a particular focus on the golgins, a set of long coiled-coil proteins that are anchored to the Golgi via carboxy-terminal domains that either bind small GTPases or span the lipid bilayer [5] [6] [7] [8] . Seven of the golgins are able to capture specific classes of Golgi-directed carriers when ectopically installed at mitochondria 11 . Of these seven, the trans-Golgi golgins golgin-97, golgin-245 and GCC88 have all been implicated in endosome-toGolgi trafficking, a pathway critical for recycling to the Golgi of the machinery that delivers lysosomal hydrolases, and also part of the route used by bacterial toxins to move from endosomes to the ER to gain access to the cytoplasm [12] [13] [14] . For all three of golgin-97, golgin-245 and GCC88, a conserved amino-terminal region is necessary and sufficient for vesicle capture, with the motifs found in golgin-97 and golgin-245 being closely related but distinct from that in GCC88 15 .
To identify candidate vesicle-associated specificity factors for these golgins, we combined ectopic golgin-mediated vesicle capture with BioID proximity biotinylation 16 . The vesicle-binding motifs from the N termini of golgin-97, golgin-245 and GCC88 were fused to the promiscuous biotin ligase BirA * , which was appended to the N terminus of a mitochondrial form of GCC185, a golgin that has no detectable vesicle capture activity when relocalized to mitochondria in the HeLa or 293T cell lines used in this study 11, 16 (Fig. 1a) . These chimaeras retain both biotinylation activity and the ability to capture endosome-to-Golgi vesicles, permitting the identification of golgin-proximal proteins by mass spectrometry of affinity-purified biotinylated proteins ( Fig. 1b and Supplementary Fig. 1a-e) . Inspecting the proteins efficiently biotinylated by the golgin-97 construct but not by the negative control revealed, as expected, cargo known to travel along the endosome-toGolgi route, such as the cation-independent mannose 6-phosphate receptor (CI-MPR) and carboxypeptidase D 17, 18 (Fig. 1c) . Comparison of the strongest specific hits that were common to both golgin-97 and golgin-245 revealed, in addition, two poorly characterized cytosolic proteins (Fig. 1d) . These are TBC1D23, a member of the TBC (Tre-2/Bub2/Cdc16) family of Rab GAPs but otherwise of unknown function 19, 20 , and FAM91A1. FAM91A1 has no known function or clear similarity to any other protein, but has been suggested to form a trimeric complex with two other proteins of unknown function, WDR11 and C17orf75, on the basis of co-fractionation and co-precipitation [21] [22] [23] . Immunoblotting of streptavidin-purified biotinylated proteins from cells expressing the different BirA * -golgin chimaeras validated the mass spectrometry results: CI-MPR was biotinylated by all three golgin constructs as expected for their endosomal vesicle capture activity, while TBC1D23 and FAM91A1 were biotinylated by golgin-97 and golgin-245, but not by GCC88, consistent with GCC88 having a N-terminal vesicle-capturing sequence that is distinct from that of the other two golgins (Fig. 1b) .
TBC1D23 and FAM91A1 co-localized with golgin-97 and golgin-245 at the trans-Golgi (Supplementary Fig. 1f ). Relocation to mitochondria of golgin-97 and golgin-245, but not GCC88, resulted in the relocation of TBC1D23 and FAM91A1 (Fig. 1e,f) . The double deletion of golgin-97 and golgin-245 by CRISPR-Cas9, but not the single deletions, resulted in the loss of targeting of both TBC1D23 and FAM91A1 to the Golgi ( Fig. 1g and Supplementary Fig. 1g,h ). Thus, golgin-97 and golgin-245 are necessary and sufficient for the recruitment of TBC1D23 and FAM91A1 to membranes.
To determine whether either TBC1D23 or FAM91A1 depends on the other for Golgi recruitment, we used CRISPR-Cas9-generated null mutants of TBC1D23 or FAM91A1 ( Supplementary Fig. 2a-d) . Loss of TBC1D23 resulted in the delocalization of FAM91A1 from the Golgi, whereas deletion of FAM91A1 did not affect the Golgi localization of TBC1D23 (Fig. 1h,i ). In neither case was the location of the golgins to the Golgi perturbed. Taken together, these results suggest that golgin-97 and golgin-245 recruit TBC1D23, and that this is then required for recruitment of FAM91A1.
We next asked whether TBC1D23 binds directly to golgin-97 and golgin-245. The conserved N-terminal regions that were used for the BioID experiments were expressed in Escherichia coli as fusions to the N terminus of GST (Fig. 2a) . Recombinant TBC1D23 expressed in E. coli bound directly in vitro to golgin-97(1-21)-GST and golgin-245(1-21)-GST but not to GCC88(1-59)-GST (Fig. 2b) . These regions of golgin-97 and golgin-245 share several highly conserved residues, of which Phe2 and Leu5 were identified by alanine scanning mutagenesis to be particularly critical for binding TBC1D23 in vitro (Fig. 2a-c) . The F2A and L5A mutations in full-length golgin-97 also abolished ectopic capture of TBC1D23 in vivo (Fig. 2d) . Taken together, these results show that TBC1D23 binds directly to the N termini of golgin-97 and golgin-245.
We next investigated whether TBC1D23 is required for the capture of endosomal vesicles by the mitochondrial forms of golgin-97 or golgin-245. In the tbc1d23 mutant, mitochondrial capture of endosomal vesicles, visualized by the endosome-to-Golgi cargo TGN46 (refs 11,18) , was markedly reduced, but rescued by reintroduction of TBC1D23 (Fig. 2e,f) . In contrast to these findings for TBC1D23, deletion of FAM91A1 had no detectable effect on the ability of mitochondrial golgin-97 to capture vesicles or recruit TBC1D23 ( Supplementary Fig. 2e ). Thus, TBC1D23 is required for vesicle capture by the golgins, whereas FAM91A1 is recruited by TBC1D23 but is not essential for vesicle capture by TBC1D23.
To test the hypothesis that TBC1D23 is an adaptor that links endosome-derived carriers to golgin-97 and golgin-245, we relocated TBC1D23 to mitochondria (TBC1D23-mito, Supplementary Fig. 3a) . As expected, TBC1D23-mito could recruit cytosolic forms of golgin-97 and golgin-245, while GCC88 remained at the transGolgi ( Supplementary Fig. 3a,b) . Strikingly, TBC1D23-mito relocated four different endosome-to-Golgi cargo proteins to mitochondria ( Fig. 3a and Supplementary Fig. 3c ). Electron microscopy revealed an accumulation of circular and oval membranes tethered between the mitochondria (Fig. 3b) , similar to that seen with the golgins 11 . Interestingly, the distance between the tethered carriers and the mitochondrial membrane was less for TBC1D23-mito, consistent with the absence of the long coiled-coil region of the golgin to act as a spacer (Fig. 3c) . While TBC1D23-mito also recruited FAM91A1, deletion of FAM91A1 had no effect on carrier relocation by TBC1D23-mito ( Supplementary Fig. 3d ). BirA * fused to the N or C terminus of TBC1D23-mito specifically biotinylated golgin-97, golgin-245, FAM91A1 and the cargo of endosome-derived carriers (Fig. 3d) , validating biochemically the results of the visual relocation assay.
The above results suggest the existence of factors on the vesicles that can bind TBC1D23. To seek such factors, we used mass spectrometry to identify the proteins that could be co-precipitated with TBC1D23 tagged with GFP at either the N or C terminus. Both of the tagged forms of TBC1D23 co-precipitated golgin-97 and golgin-245 along with FAM91A1 and its putative binding partners WDR11 and C17orf75 (Fig. 3e) . The only other strong hits in the precipitates that were not chaperones or abundant cytosolic enzymes were FAM21, the largest subunit of the pentameric WASH complex (Wiskott-Aldrich syndrome protein and SCAR homologue), and FKBP15, a known interaction partner of FAM21 (refs 24,25) . The WASH complex is recruited to carriers forming on endosomes, including those that return to the Golgi, and coordinates the recruitment of membrane traffic components and actin filaments [25] [26] [27] . To understand the contribution that the golgins, FAM91A1 and the WASH complex make to the mechanism by which TBC1D23 links golgin-97 and golgin-245 to vesicles, we mapped the domains of TBC1D23 that are responsible for its different interactions. Truncated forms of TBC1D23 were fused to BirA * , ectopically localized to mitochondria, and then interacting proteins were identified by proximity biotinylation (Fig. 3f) . The first 331 residues of TBC1D23, including the TBC domain, were sufficient to biotinylate golgin-97 and golgin-245 but not the subunits of the putative FAM91A1 complex or the vesicle resident protein CI-MPR (Fig. 3g) . In contrast, residues 514-559 were specific for FAM91A1 and its associated proteins, with FAM91A1 itself binding directly to this region ( Fig. 3g and Supplementary Fig. 4a ). Finally, residues 559-684 were specific for the cargo of endosome-derived carriers (Fig. 3g) . Thus, distinct parts of TBC1D23 bind to the golgins, to FAM91A1 and to endosome-derived carriers.
Strikingly, the WASH subunit FAM21 and its known binding partner FKBP15 were biotinylated by the part of TBC1D23 that binds carriers but not by the parts that bind the golgins or FAM91A1 (Fig. 3g) . Moreover, affinity chromatography of cytosol with recombinant fragments of TBC1D23 revealed that the C-terminal carrierbinding region bound to WASH subunits (Fig. 3h) , and this region was sufficient to recruit to mitochondria both exogenous FAM21A-GFP and the endogenous WASH subunit WASH1 (Fig. 4a,b) . In humans FAM21 is encoded by two genes that express proteins that are 99% identical (FAM21A/WASHC2A and FAM21C/WASHC2C), and for this study, we have used FAM21A, as it has been used in previous work and is the predominant form in HeLa cells 25, 28 . FAM21 is responsible for linking the WASH complex to a range of different proteins by interactions it makes through a long unstructured tail that contains repeats of a conserved motif 24, 27, 29 . The entire unstructured tail of FAM21A (residues 357-1341) can be expressed in E. coli
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, and we found that this recombinant form of the tail bound directly to residues 559-684 of TBC1D23, but not to the regions of TBC1D23 GST fusions on beads that bind to the golgins or to the FAM91A1 complex (Fig. 4c) . A similar pattern of binding was observed for the entire WASH complex, confirming that the interaction with FAM21 can occur in the context of the WASH complex ( Supplementary Fig. 4b ). Finally, by using recombinant proteins expressed in E. coli, we could show that the presence of TBC1D23 allowed the FAM21A tail to bind to residues 1-21 of golgin-97, indicating that TBC1D23 acts as a bridging protein by binding simultaneously to the golgins and to FAM21A (Fig. 4d) . The in vivo assays of TBC1D23 function described above use a direct assay of vesicle tethering, but one that occurs at tagged with GFP at either the N or C terminus. Identified are the golgins, the three subunits of the putative FAM91A1 complex, and the WASH complex subunit FAM21 and its interactor FKBP15. Other proteins found at comparable levels were abundant cytosolic proteins or nuclear proteins that are most likely nonspecific interactions (i, ZBTB33; ii, fatty acid synthase; iii, Grp78; iv, mitoHsp70; v, Hsc71; with Hsp70 being beyond the axes). mitochondria. Thus, we investigated whether TBC1D23 is required for endosome-to-Golgi trafficking itself. TGN46 provides an ideal cargo for such analysis as it is well established to cycle between endosomes and Golgi, and, when retrieval from endosomes is perturbed, it is diverted to lysosomes and degraded, thus allowing efficacy of retrieval to be quantified by both immunofluorescence and blotting
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. Examination of cells lacking TBC1D23 showed that the accumulation of TGN46 in the Golgi and its overall level were significantly reduced (Fig. 5a,b and Supplementary Fig. 4c,d) . A similar effect on TGN46 was observed when both golgin-97 and golgin-245 were deleted, consistent with TBC1D23 and the golgins acting in the same process, and indeed rescue of the golgin double deletion by golgin-245 required the presence of the N-terminal 21 residues that bind TBC1D23 (Fig. 5c,d and Supplementary Fig. 4c-e) . The endosome-to-Golgi trafficking of another well-established cargo, CI-MPR, can be assayed using antibody uptake, and again deletion of the golgins or of TBC1D23 perturbed this process (Fig. 5e,f) . The WASH complex has been reported to be required for normal endosome-to-Golgi trafficking of CI-MPR and TGN46 (refs 25,26, 31) , and we could confirm that depletion of FAM21A also caused a reduction in the levels of TGN46 (Supplementary Fig. 4f ). The defect in endosome-to-Golgi trafficking in the tbc1d23 cells could be restored by expression of full-length TBC1D23 but not by a truncated form lacking residues 559-684 that bind to FAM21A (Fig. 5g) . In contrast, deletion of FAM91A1 did not affect TGN46 levels, suggesting that it is not essential for tethering but might instead have a regulatory or cell-type-specific role ( Supplementary Fig. 4c ).
Our findings are consistent with a model in which TBC1D23 is a modular bridging factor whose separate domains link the tips of golgins at the trans-Golgi to incoming endosome-derived carriers (Fig. 5h) . Furthermore, the carrier-binding domain of TBC1D23 interacts with the FAM21 subunit of the WASH complex and hence is directly contacting these carriers. TBC1D23 is conserved outside of metazoans, indicating that it was present in the last eukaryotic common ancestor ( Supplementary Fig. 5 ). It has been lost in non-basal fungi, and interestingly the components of the WASH complex show a closely related pattern of evolutionary conservation. However, the WASH complex is recruited to more than one of the types of carrier leaving endosomes, as it interacts with retromer, which is involved in transport to both the plasma membrane and to the Golgi 24, 25, 29, 32 . Thus, it seems likely that TBC1D23 makes additional interactions with the carrier to select only those carriers destined for the Golgi 
Golgin-245
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Golgin-97 To ensure specificity, TBC1D23 may well bind further factors on the vesicle (X) in addition to FAM21, as the latter is also involved in generating vesicles on endosomes that are destined for the plasma membrane. The FAM91A1 complex is not required for tethering in our assays and so may augment or regulate tethering or downstream events, or act only under particular circumstances. Unprocessed original scans of blots are shown in Supplementary Fig. 6 . Experiments were repeated three times, except that in e, which was performed twice.
( Fig. 5h) . Although the TBC domain in TBC1D23 lacks the arginine and glutamine residues that are conserved in most TBC proteins and are essential for Rab GAP activity 20 , it could conceivably bind to a Rab, although in our assays this domain was neither necessary nor sufficient for vesicle capture. In addition, the role of the rhodanese-like domain in TBC1D23 is unclear-it is found in combination with other domains in a range of proteins with diverse roles including phosphatases, heat-shock proteins and ubiquitin hydrolases 33 . What is clear is that there is no shortage of other proteins on endosome-to-Golgi carriers that TBC1D23 could potentially bind to in conjunction with the WASH complex. Indeed, the question of how endosome-derived carriers are generated is currently debated, as some components such as retromer and WASH apparently act in multiple routes, whereas other components have been proposed to act independently in the same route. For example, both the AP-1 clathrin adaptor and the sorting nexins SNX1/2 have been reported to direct retrieval of proteins from endosomes to the Golgi 34,35 . Thus, it seems possible that multiple partially redundant mechanisms operate in parallel, confounding experimental dissection. Indeed, the observation that GCC88 captures CI-MPR-containing vesicles independently of TBC1D23 strongly suggests that either there are at least two types of endosome-to-Golgi carrier with overlapping cargos, or there are two mechanisms for capture of the same vesicles. Interestingly, two recent studies report that truncating mutations in human TBC1D23 are not cell lethal but lead to impaired brain development, consistent with there being additional mechanisms to sustain endosome-to-Golgi trafficking 36,37 .
Our work has also revealed that TBC1D23 interacts with FAM91A1, a protein of unknown function, but the FAM91A1-interacting domain of TBC1D23 is neither necessary nor sufficient for capture of endosome-derived carriers, at least in the context of the mitochondrial relocation assay (Fig. 3g) . FAM91A1 has been proposed to form a trimer with WDR11 and C17orf75, two proteins identified in a genome-wide short interfering RNA (siRNA) screen for modifiers of sensitivity to the toxin ricin as enhancing toxin transport from the cell surface to the ER 21, 22 . It is possible that the FAM91A1 interaction acts to regulate or augment vesicle capture by TBC1D23, or to aid capture of a specific sub-population of vesicles that our assays do not detect. Our data also do not preclude it acting at other locations in the endocytic pathway in addition to the Golgi, such that its removal results in increased surface exposure of some recycling membrane proteins including receptors for toxins.
In conclusion, TBC1D23 defines a bridge that mediates the recognition of an incoming vesicle by its destination compartment. The surprisingly extensive nature of this bridge is perhaps necessitated by the extremely crowded cytosolic environment. Indeed, large tethering complexes appear to be a common theme in most, if not all, intracellular trafficking pathways. Defining the requisite interactions that impart both specificity and efficiency to vesicle capture, as done here for two golgins, will be crucial to understand the molecular basis of membrane organization. The strategy of ectopic tether localization for both the functional analysis of capture and the identification of candidate specificity factors should prove widely useful in this area.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. 
Plasmids. BioID plasmids were as follows: BirA * followed by a GSGSGS linker attached to the N terminus of GCC185 Cterm-HA-MAO 11 , to generate BirA * -GCC185 Cterm-HA-MAO in pcDNA3.1+ (pJJS127) or pcDNA5/FRT/TO (pJJS138). Golgin-97(1-21), golgin-245(1-21) and GCC88(1-59) followed by linker GGGGSLVPRGSGGGGG attached to the N terminus of BirA * -GCC185 Cterm-HA-MAO in both pcDNA3.1+ and pcDNA5/FRT/TO versions to generate golgin-97(1-21)-BirA * -GCC185 Cterm-HA-MAO (pJJS129 and pJJS140), golgin-245(1-21)-BirA * -GCC185 Cterm-HA-MAO (pJJS130 and pJJS141) and GCC88(1-59)-BirA * -GCC185 Cterm-HA-MAO (pJJS131 and pJJS142) respectively. All TBC1D23 plasmids for mammalian cell expression were based on a mouse cDNA encoding the 684-residue form that lacks alternatively spliced exon 15. TBC1D23-BirA * -HA-MAO plasmid in pcDNA3.1+ (pJJS249) and pcDNA5/FRT/TO (pJJS239) consist of TBC1D23(1-684) followed by a linker GSGSGS, BirA * , linker GGSGGGGG and HA-MAO. The BirA * -TBC1D23-HA-MAO plasmid in the pcDNA5/FRT/TO (pJJS237) vector consists of BirA * , a GSGSGSG linker, TBC1D23(1-684), a GGSGGGGG linker and HA-MAO. For the truncated TBC1D23-BirA * -MAO plasmids, TBC1D23(1-684) in pJJS249 was replaced with TBC1D23(1-331), (1-513), (272-684), (332-684), (514-684), (559-684) and (514-558) to generate pJJS255, pJJS256, pJJS257, pJJS258, pJJS259, pJJS273 and pJJS272, respectively.
CRISPR-Cas9 used the plasmids eSpCas9 (Addgene no. 71814) and pIRESpuro3 (Clontech). eSpCas9 was digested with BbsI and the following gRNA sequences were inserted by annealed oligonucleotide cloning: 5 -CTGCCAACGTCGAGC GGCGA-3 targeting human TBC1D23 (pJJS291); 5 -TGAACAGATACGGAAG TTAG-3 targeting human GOLGA1 (pJJS288); 5 -GTCCTGCTCCTCATTCT TGT-3 targeting human GOLGA4 (pJJS290); and 5 -CACCACACAAATGAGTG ATG-3 targeting human WASHC2C (FAM21A and FAM21C) (pJJS335).
AF120, GAG-POL and VSVG plasmids for retroviral transduction were provided by F. Randow (MRC-LMB). Mouse TBC1D23 was cloned into AF120 between NcoI and NotI (pJJS271). The bicistronic construct expressing mitochondrial APEX and TBC1D23-HA-MAO (pJJS243), was made by replacing the golgin in Mito-APEX golgin-97 Cterm-HA-MAO (pMX0167) with TBC1D23 11 . Bacterial expression used E. coli codon-optimized cDNAs for human TBC1D23 (684-residue form, Uniprot Q9NUY8-2) or FAM21A. For N-terminal GST fusions, regions of TBC1D23 were amplified and cloned into pGEX6p2 using EcoR1 and XhoI (GE Healthcare Life Sciences). For C-terminal GST fusions, pOPT (O. Perisic, MRC-LMB) was modified to insert residues 1-21 of golgin-97, 1-21 of golgin-245 and 1-59 of GCC88 upstream of a GSGSGS linker and GST using NdeI and SacII. Site-directed mutagenesis and DpnI digestion was used to mutagenize the golgin N termini. For TBC1D23-His 6 , the E. coli codon-optimized form was amplified with a GAGA linker and His 6 tag in the reverse primer and cloned into pOPT using NdeI and BamH1. E. coli optimized FAM21A 356-1341 was cloned into pETM-41 between NcoI and BamHI. Golgin-97 Cterm (1-Val681) and golgin-245 C-term (1-Gly2163) were expressed in pcDNA3.1+ (Clontech) upstream of a GAGAGA linker, an HA tag and a mitochondrial targeting sequence (MAO, residues 481-527); Myc-golgin-245 pSVT7 and FAM21A-GFP were as published 38, 39 .
Cell culture, transfection and immunofluorescence. Cell lines HeLa (ATCC), 293T
(ATCC) and 293T Flp-In T-REx (ThermoFisher Scientific, R78007) were cultured in Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 10% fetal calf serum (FCS) and penicillin/streptomycin at 37 • C and 5% CO 2 unless otherwise stated. The fam91a1 mutant and its WT parent HAP1 cell line were purchased from Horizon Discovery, with FAM91A1-001 having been targeted using the guide 5 -GTTGATAAGATCATCGATTC-3 . Cell lines were authenticated as being human by mass spectrometry, and the cell line lacking FAM91A1 authenticated by immunoblotting. All cell lines were tested regularly to ensure that they were mycoplasma free (MycoAlert, Lonza). For immunofluorescence, cells were transfected with plasmid DNA using FuGENE 6 according to the manufacturer's instructions (Promega). Cells were fixed with 4% formaldehyde in PBS and permeabilized in 0.5% (v/v) Triton X-100 in PBS. Cells were blocked for one hour in PBS containing 20% FCS and 0.25% Tween-20 and probed in the same buffer with primary antibodies (Supplementary Table 2 ) and then Alexa-labelled secondary antibodies (Molecular Probes). The cells were mounted in Vectashield (Vector Laboratories) and imaged using LSM 780 (Zeiss) or TCS SP8 (Leica) confocal microscopes. For quantification of TGN46, cells and the Golgi were defined with DAPI and ZFPL1, respectively (NISElements, Nikon). The Golgi mask had a minimum threshold of 18% of the mean ZFPL1 Golgi labelling to exclude out-of-focus Golgi.
Generation of CRISPR knockout and rescued cell lines.
HeLa cells grown in 6-well plates to ∼70% confluence were transfected with 0.5 µg pIRESpuro3 and 1.5 µg of pJJS288, pJJS290 or pJJS291 using 6 µl FuGENE 6 in 200 µl Opti-MEM. The cells were trypsinized one day later and diluted into 96-well plates in medium containing 1 µg ml −1 puromycin, which was replaced with non-selective medium 24 h later. Single colonies were expanded and analysed by immunofluorescence and immunoblotting. To rescue the tbc1d23 mutant HeLa cell line, the plasmid pJJS271 was used for retroviral-based packaging from 293T cells, and the supernatant was used to transduce tbc1d23 cells grown to ∼50% confluence. The medium was changed one day later, and the cells were trypsinized two days after transduction and diluted into 96-well plates in medium containing 5 µg ml −1 blasticidin. Single colonies were expanded and analysed by immunofluorescence and immunoblotting.
siRNA knockdown of TBC1D23. ON-TARGETplus Human TBC1D23 (55773) siRNA SMARTpool was purchased from Dharmacon GE, which targeted 5 -AGAG AUCCUUCAAGCGAAU-3 , 5 -GGGAGAUUGUUUCACGGAA-3 , 5 -GCGCUG AAUUCUGUAGUUA-3 and 5 -CCGUUAAUGUCAGGGAAAA-3 of TBC1D23. HeLa cells at ∼30% confluence were resuspended in DMEM medium lacking FCS and antibiotics and transfected with 2 µM of siRNA using Oligofectamine (ThermoFisher Scientific). This step was repeated after one day, and after two further days the cells were analysed by immunofluorescence and immunoblotting.
Generation of doxycycline-inducible cell lines. 293T Flp-In T-REx cell lines containing doxycycline-inducible BirA * -GCC185 Cterm-HA-MAO, golgin-97(1-21)-BirA * -GCC185 Cterm-HA-MAO, golgin-245(1-21)-BirA * -GCC185 Cterm-HA-MAO, GCC88(1-59)-BirA * -GCC185 Cterm-HA-MAO, BirA * -TBC1D23-MAO and TBC1D23-BirA * -MAO were generated according to the manufacturer's instructions. Briefly, 293T Flp-In T-REx cells were grown in 6-well plates to ∼50% confluence and transfected with 1 µg pOG44 and 1 µg pcDNA5/FRT/TO-based plasmid using 6 µl FuGENE 6 in 200 µl of Opti-MEM. The medium was replaced after one day, and after two days cells were trypsinized, expanded in medium containing 100 µg ml −1 hygromycin, and verified by induction of expression with 1 µg ml −1 doxycycline and immunoblotting for the HA epitope.
Affinity capture of biotinylated proteins. The protocol for isolating proteins biotinylated by BirA * was adapted from the BioID method 16 . Briefly, 293T Flp-In T-REx cell lines containing the BirA * constructs were grown in two 175 cm 2 flasks in DMEM supplemented with 10% tetracycline-free FCS to ∼70% confluence. Biotin (50 µM; 10 mg ml −1 stock in dimethylsulfoxide) and 1 µg ml −1 doxycycline (1 mg ml −1 stock in dimethylsulfoxide) were added, and the cells were incubated for 24 h before lysing. For transient transfections, 293T cells were grown in two 175 cm 2 flasks to ∼50% confluence and transfected with 25 µg plasmid and 75 µl FuGENE 6 in 5 ml Opti-MEM. One day after transfection, biotin was added to 50 µM, and the cells were incubated for a further day. For lysis, cells were trypsinized, pelleted by centrifugation (500g , 10 min), washed twice in PBS and resuspended in 1 ml lysis buffer (50 mM Tris pH 7.4, 0.1 M NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM phenylmethyl sulfonyl fluoride (PMSF), cOmplete protease inhibitor cocktail (Roche)), and incubated on ice for 20 min. After centrifugation at 13,000g for 5 min at 4 • C, the supernatants were mixed with 1 ml of 50 mM Tris pH 7.4. Five per cent of this sample was saved for immunoblotting, and the rest was added to 500 µl Dynabeads MyOne Streptavidin C1 beads (Invitrogen) that had been pre-washed twice in the same buffer. The beads were incubated at 4 • C overnight, washed twice in wash buffer 1 (2% SDS-PAGE, cOmplete inhibitors), three times in wash buffer 2 (1% Triton X-100, 0.1% deoxycholate, 500 mM NaCl, 1 mM EDTA, 50 mM HEPES, cOmplete inhibitors, pH 7.5), and three times in wash buffer 3 (50 mM Tris pH 7.4, 50 mM NaCl, cOmplete inhibitors). Finally, the beads were incubated in 50 µl SDS sample buffer containing 10% β-mercaptoethanol and 3 mM biotin at 98 • C for 5 min to dissociate the biotinylated proteins from the beads; 30 µl was run on a gel for mass spectrometry, with the remainder reserved for immunoblotting.
In vitro binding assays using recombinant proteins. Golgin N termini fused to GST, TBC1D23-His 6 and His 6 -MBP-FAM21(356-1341) were expressed in the E. coli strain BL21-GOLD (DE3; Agilent Technologies). Bacteria were grown at 37 • C to an OD 600 nm of 0.7 and induced with 100 µM IPTG overnight at 15 • C. Cells were harvested by centrifugation, dounce homogenized and sonicated in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM PMSF and cOmplete inhibitors). Lysates were clarified by centrifugation at 12,000g for 15 min at 4 • C. Lysates containing golgin NT-GST fusions were applied at saturating concentrations to glutathione-Sepharose beads (GE Healthcare) for 1 h with rotation at 4 • C. Beads were washed once in high salt buffer (lysis buffer containing 500 mM NaCl), followed by several washes in lysis buffer. Lysate from bacteria expressing TBC1D23-His 6 was also incubated with glutathione-Sepharose beads to pre-clear the sample prior to incubation with 50 µl golgin NT-GST-coated beads for 1 h with rotation at 4 • C. Beads were washed extensively in lysis buffer. In some experiments, an additional incubation with pre-cleared lysate from bacteria expressing His 6 -MBP-FAM21(356-1341) was also performed for 1 h at 4 • C before further washes in lysis buffer. In all cases, samples were eluted in SDS sample buffer containing 1 mM β-mercaptoethanol. Five per cent of each eluate and 1% of the total lysates were separated on SDS-PAGE gels and stained with Coomassie DOI: 10.1038/ncb3627
InstantBlue (Expedeon). The interaction between GST-FAM21(356-1341) expressed in pGEX6p2, TBC1D23 expressed without a tag, and golgin-97 and golgin-245 (residues 1-21) fused to MBP-His 6 was performed essentially as described above; likewise for the interaction between FAM91A1(1-328)-His 6 and GST fusions to TBC1D23 fragments expressed in pGEX6p2.
Affinity chromatography using GST-TBC1D23 fragments. Glutathione-Sepharose beads saturated with GST-TBC1D23 fusion proteins were incubated with lysates from two confluent 175 cm 2 flasks of 293T cells. 293T cells were collected by centrifugation, washed once in ice-cold PBS and lysed in lysis buffer (25 mM TrisHCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 1 mM PMSF, cOmplete inhibitors) followed by clarification by centrifugation. Lysates were precleared on glutathione-Sepharose beads prior to a 2 h incubation with TBC1D23-coated beads. Beads were washed extensively in lysis buffer and proteins were eluted first with high-salt elution buffer (25 mM Tris-HCl, 1.5 M NaCl, 1 mM EDTA) to release interacting proteins, and then SDS sample buffer to release the GST-fusion proteins. Proteins were chloroform/methanol-precipitated from the high-salt eluate and resuspended in SDS sample buffer containing 1 mM β-mercaptoethanol. Lysates and eluates were separated by SDS-PAGE and analysed either by mass spectrometry or transferred to nitrocellulose for immunoblotting.
Immunoprecipitation of GFP-tagged TBC1D23. Two 175 cm 2 flasks of 293T cells at ∼75% confluency were transfected with plasmids encoding GFP-tagged TBC1D23 using FuGENE 6 according to the manufacturer's instructions. Cells were harvested by centrifugation, washed once in ice-cold PBS and lysed in lysis buffer (25 mM TrisHCl pH 7.4 150 mM NaCl, 0.5 mM EDTA, 0.5% (V/V) Triton X-100, 1 mM PMSF cOmplete inhibitors) for 30 min at 4 • C. Lysates were clarified by centrifugation before GFP-tagged proteins were isolated by incubation with 25 µl of packed GFPTrap beads (Chromotek) for 2 h with rotation at 4 • C. Beads were washed in lysis buffer and bound proteins eluted by the addition of 100 µl 2 × SDS sample buffer.
Eluates were analysed by mass spectrometry and immunoblotting.
Purification of the WASH complex from mWASH 293 cells. The WASH complex was purified from 293 cells stably expressing His 6 -Protein C tagged murine WASH1 as described previously 40 . Briefly cells from eight T150 flasks were pelleted by centrifugation at 500g for 5 min at 4 • C, washed in PBS and resuspended in lysis buffer (200 mM NaCl, 1 mM CaCl 2 , 1% Triton X-100, 50 mM Na-HEPES, pH 7.4). Cells were lysed by rotation in lysis buffer at 4 • C for 1 h, centrifuged at 13,000g for 15 min and the supernatant rotated with 100 µl PC affinity resin for 4 h at 4 • C. The beads were washed once in lysis buffer, once in WHB1 buffer (200 mM NaCl, 1 mM CaCl 2 , 0.02% methyl-cellulose, 50 mM Na-HEPES, pH 7.4) and once in WHB2 buffer (WHB1 without CaCl 2 ) prior to elution by Ca 2+ chelation using WHB2 supplemented with 5 mM EGTA. The eluate was incubated with 100 µl glutathioneSepharose resin saturated with GST-TBC1D23 fusions and affinity purification was performed as described above.
Mass spectrometry. Samples were loaded on 4-20% Tris-glycine SDS-PAGE gels and run for 1-2 centimetres. Proteins were stained with Coomassie InstantBlue, and the entire gel lane was cut into eight slices that were placed in a 96-well plate and destained with 50% v/v acetonitrile and 50 mM ammonium bicarbonate, reduced with 10 mM dithiothreitol, and alkylated with 55 mM iodoacetamide. Digestion was with 6 ng µl −1 trypsin (Promega) overnight at 37 • C, and peptides were extracted in 2% v/v formic acid 2% v/v acetonitrile, and analysed by nanoscale capillary LC-MS/MS (Ultimate U3000 HPLC, Thermo Scientific Dionex) at a flow of ∼300 nl min −1 . A C18 Acclaim PepMap100 5 µm, 100 µm × 20 mm nanoViper (Thermo Scientific Dionex) trapped the peptides prior to separation on a C18 Acclaim PepMap100 3 µm, 75 µm × 250 mm nanoViper. Peptides were eluted with an acetonitrile gradient. The analytical column outlet was interfaced via a nano-flow electrospray ionization source with a linear ion trap mass spectrometer (Orbitrap Velos, Thermo Scientific). Data-dependent analysis was performed using a resolution of 30,000 for the full MS spectrum, followed by ten MS/MS spectra in the linear ion trap. MS spectra were collected over an m/z range of 300-2,000. MS/MS scans were collected using a threshold energy of 35 for collisioninduced dissociation. LC-MS/MS data were searched against the UniProt KB database using Mascot (Matrix Science), with a precursor tolerance of 5 ppm and a fragment ion mass tolerance of 0.8 Da. Two missed enzyme cleavages and variable modifications for oxidized methionine, carbamidomethyl cysteine, pyroglutamic acid, phosphorylated serine, threonine and tyrosine were included. MS/MS data were validated using the Scaffold programme (Proteome Software).
Immunoblotting. One 75 cm
2 flask of cells at ∼90% confluence was harvested by scraping and centrifugation, washed twice with ice-cold PBS, resuspended in 300 to 500 µl lysis buffer (50 mM Tris pH 7.4, 0.1 M NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM PMSF, cOmplete inhibitors) for 30 min on ice, clarified by centrifugation, and protein concentration was determined (Bio-Rad). Lysate concentrations were normalized, and the lysates were boiled in NuPAGE SDS sample buffer containing 10% β-mercaptoethanol at 90 • C for 5 min, run on a gel and transferred to nitrocellulose. All blots, except for those with Streptavidin-HRP, were blocked in 5% (w/v) milk in PBS-T (PBS with 0.1% (v/v) Tween-20) for 1 h, incubated overnight at 4 • C with primary antibody in the same blocking solution (Supplementary Table 2 ), washed three times with PBS-T for 5 min, incubated with HRP-conjugated secondary antibody in 0.1% (w/v) milk in PBS-T for 1 h, washed five times with PBS, and detected with either Immobilon Western HRP substrate or Amersham ECL detection reagent. For Streptavidin-HRP blocking (1 h), incubation (1 h) and washing (five times) were all in PBS 2.5% FCS 0.4% Triton X-100.
Electron microscopy. HeLa cells were grown on glass-bottom Petri dishes (MatTek) to 70% confluency and transfected with pJJS243 or pMX0167. After 36 h, they were fixed at room temperature in 2% glutaraldehyde (EM grade, Agar Scientific) in 0.1 M cacodylate buffer at pH 7.4 (CB) for 30-60 min on ice. Cells were rinsed five times with CB for 2 min, blocked in 50 mM glycine in CB for 5 min on ice, and rinsed in CB again. For APEX-catalysed oxidation of 3,3-diaminobenzidine (DAB), freshly prepared 0.5 mg ml −1 DAB freebase (Sigma) in HCl and 0.03% H 2 O 2 (10 mM; Sigma) was added and on the formation of a brown precipitate (∼15 min), the reaction was halted by rinsing with CB fives times. Samples were post-fixed with 1% OsO 4 in CB for 1,h in the dark and on ice, rinsed 5 times for 10 minutes in chilled deionized water, dehydrated in a chilled ascending ethanol series (30%, 50%, 70%, 90%, 100%) with 100% ethanol at room temperature, then infiltrated with CY212 epoxy resin and polymerized. Areas containing dark granules were excised, mounted onto dummy resin blocks and sectioned using a Leica ultramicrotome parallel to the substratum. Pale gold 70 nm sections were contrasted with saturated aqueous uranyl acetate and Reynold's lead citrate. Electron micrographs were recorded at 80 kV on an FEI Technai Spirit TEM. The distance between mitochondrial membranes was measured using the segmented lines tool in ImageJ.
CI-MPR transport assay.
To monitor retrograde CI-MPR traffic, cells were incubated at 37 • C with 10 µg ml −1 anti-CI-MPR antibody in serum-free DMEM for 10 min, rinsed with ice-cold PBS, then low-pH solution (300 mM NaCl, 5 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 0.2 M acetic acid, pH 2.5), then PBS, then chased with antibody-free medium for 45 min at 37 • C, and then fixed and immunostained for the internalized antibodies. DAPI and giantin were used to define individual cells and the Golgi, respectively, using NIS-Elements. The Golgi mask had a minimum threshold of 30% of the mean giantin Golgi labelling to exclude out-of-focus Golgi. The ratio of the mean intensity of CI-MPR within the Golgi over total CI-MPR inside the cell was quantified to obtain the final CI-MPR internalization ratio.
Statistics and reproducibility. Statistical differences between data sets were analysed using unpaired, two-tailed Mann-Whitney tests using Prism 7, with n and P values stated in the figure legends. All microscopy experiments were repeated independently three times with similar results, with the exception of Figs 3b and 5e, and Supplementary Figs 1b and 3b,d , which were repeated twice with similar results. All biochemical experiments were repeated independently three times with similar results, with the exception of Figs 1b, 2c, 4d and Supplementary Fig. 4a,b, Binding of WASH complex to beads coated with as in (a). The WASH complex was purified from a mammalian cell line expressing His-PC-TEV-WASH1 1 , and applied to the beads. Salt-eluates were probed for WASH1, and subsequent SDS eluates stained to show the GST fusions. (c) Immunoblots of HeLa cell extracts quantifying TGN46 and CI-MPR upon deletion of the indicated genes. Two independent replicates of Figs. 8b and 8d illustrate the robustness of the effects. Deletion of TBC1D23, or both golgin-97 and golgin-245, but not FAM91A1 results in degradation of TGN46 but not CI-MPR, consistent with previous reports that when CI-MPR does not return to the TGN it recycles to the surface in contrast to TGN46 which proceeds to lysosomes 2, 3 . A previous study also observed a differential effect on the two proteins when TGN function was disrupted 4 The rescue of Golgi accumulation of TGN46 requires residues 2-21 in golgin-97 that bind TBC1D23. Scale bars 10 µm. (f) Immunoblots of HeLa extracts to quantify TGN46 in cells treated with CRISPR/Cas9 directed at FAM21A. Despite using a cloned line there is residual FAM21, probably reflecting it being encoded by two near identical genes and the antibody recognising both. The reduction of TGN46 is consistent with previous reports that endosome-to-Golgi traffic is perturbed by inhibiting FAM21 activity or depleting WASH subunits 1, 5, 6 . Unprocessed original scans of blots are shown in Supplementary Fig. 6 . Experiments were repeated 3 times except (a, b, f) which were performed twice.
Supplementary Figure 5 Supplementary Figure 5 Evolutionary conservation of TBC1D23 and the subunits of the FAM91A and WASH complexes. Coloured dots indicate the presence of a predicted orthologue to the human protein for each species. Orthologues were detected using HMMER3 to search with an HMM profile in each species 7 . The HMM profile was initially constructed using the phmmr reciprocal-best-hits to the human query, and then expanded (using a diminishing bit-score threshold) in stages as further orthologues were detected using hmmsearch, accepting sequences that reciprocally hit the human query or a close paralogue (>97% sequence identity) until no additional sequences were detected. All profile alignments were constructed with Clustal Omega 8 , accepting only positions a maximum gap representation of 90%. The species dendrogram represents known consensus phylogenetic relationships but branch lengths do not carry meaning. Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design
Sample size
Describe how sample size was determined. N was chosen to be large enough to cover a wide range of possible effect sizes
Data exclusions
Describe any data exclusions.
To quantify TGN46 in the Golgi, the ZFPL1-based Golgi mask had a minimum threshold of 30% of the mean ZFPL1 Golgi labeling to exclude out of focus Golgi.
To quantify CI-MPR in the Golgi, the giantin-based Golgi mask had a minimum threshold of 30% of the mean giantin Golgi labeling to exclude out of focus Golgi.
Replication
Describe whether the experimental findings were reliably reproduced.
All experimental findings were reliably reproduced
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
When cultured cells were compared under different conditions or with different antibodies, a single population was resuspended by trypsinization and randomly divided into groups of cells to be compared.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
For those experiments where objective quantitative assays were used blinding was not required. For immunofluorescence experiments where cells were selected for imaging, investigators were not blinded but the experiments were independently repeated by two individuals.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
